ABIONYX (EPA:ABNX) | Finanzwire

PRESS RELEASE

published on 08/21/2025 at 23:15, 1 year 2 months ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
ABIONYX Pharma discloses monthly statement of total voting rights and shares on Euronext Paris. Company focused on innovative medicines in rare diseases

Euronext Paris Shares Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF

published on 07/03/2025 at 19:40, 1 year 3 months ago

ABIONYX Pharma Half-Yearly Liquidity Contract Report

Liquidity Contract TP ICAP Financial Report Share Trading ABIONYX Pharma
PRESS RELEASE

published on 07/03/2025 at 19:35, 1 year 3 months ago

Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
ABIONYX Pharma releases half-yearly report showing assets in liquidity account with TP ICAP (Europe) SA, including shares and cash balance

Liquidity Contract Half-yearly Report Assets ABIONYX Pharma TP ICAP SA
BRIEF

published on 06/27/2025 at 19:19, 1 year 4 months ago

ABIONYX Pharma Secures Approval for All General Meeting Resolutions

Shareholder Approval General Meeting Biotech Innovation ABIONYX Pharma ApoA-I Technology
PRESS RELEASE

published on 06/27/2025 at 19:14, 1 year 4 months ago

Inside Information / Other news releases
ABIONYX Pharma announces approval of all resolutions at Combined General Meeting. The biotech company is dedicated to innovative therapies

General Meeting Innovative Therapies Biotech Company Resolutions Approval ABIONYX Pharma
BRIEF

published on 05/06/2025 at 21:38, 1 year 5 months ago

ABIONYX: Information on Voting Rights and Share Capital

Euronext Paris Share Capital Voting Rights Actions ABIONYX
PRESS RELEASE

published on 05/06/2025 at 21:33, 1 year 5 months ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025

Euronext Paris Shares Total Voting Rights ABIONYX Pharma April 30 2025
BRIEF

published on 03/21/2025 at 07:35, 1 year 7 months ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 year 7 months ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
BRIEF

published on 02/28/2025 at 07:35, 1 year 8 months ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease

Published on 10/30/2026 at 23:35, 2 days 10 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 10 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 12 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 14 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 18 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 09:20, 19 minutes ago

Original-Research: SFC Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/02/2026 at 09:00, 39 minutes ago

Original-Research: Gallmetzer HealthCare SpA (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 39 minutes ago

Original-Research: bet-at-home.com AG (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 40 minutes ago

Mutares has sold SRT Group and its subsidiaries to Quiver
Published on 11/02/2026 at 09:00, 40 minutes ago

hep global increases revenue and EBIT in the first half of 2026

View all EQS

Published on 10/30/2026 at 23:00, 2 days 10 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 12 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 15 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 21 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 3 days ago

Share buyback

View all LES ECHOS COMFI WIRE

News